K-BD Group Hosts 1st Investment Forum of 2022
Promoting Open Innovation Ecosystem through Strengthened Linkages
This investment forum, hosted by the Korea Drug Development Fund and jointly organized by K-BD Group and the Ajou Advanced Medical Bio Research Institute, has 9 participating institutions and universities including N4U Technology Holdings, Daekyung Technology Holdings, Sogang University Industry-Academic Cooperation Foundation, Sookmyung Women's University Technology Holdings, Ewha Womans University Technology Holdings, Ajou University Technology Holdings, SYP Co., Hongneung Small District Business Division, and Seoul Asan Hospital Bio Core Facility Center.
Companies participating in the IR presentations include Oncure Gen, Cursus Bio, Repure Healthcare, PRGS&Tech, RudaCure, GH Pharm, Medihelp Line, Trial Informatics, Wnt Bio, Cosmos Whale, Kaiser Bio, Korea CRO, Iretech Korea, Heaven Bio, Silico Pharm, Aim System, Goodbing Center, EwaI Liner, F-In Company, and Phytomap — a total of 20 companies.
Source: Pharmnews (http://www.pharmnews.com)
